Related Experiment Video
Updated: May 20, 2026

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
Morbidity and Mortality Rates in People with Diabetes Mellitus With an Active Charcot's Neuro-Osteoarthropathy: A
Dipen Patel1, Catherine Gooday1,2,3, Ian Nunney1
1Norwich Medical School, University of East Anglia, Norwich, Norfolk, NR4 7TJ, UK.
Insights
Charcot neuro-osteoarthropathy (CN) in diabetes patients leads to high amputation and mortality risks. Early, aggressive intervention targeting multiple risk factors is crucial for better outcomes in CN patients.
Area of Science:
- Diabetology
- Podiatry
- Vascular Surgery
Background:
- Diabetes-related Charcot neuro-osteoarthropathy (CN) significantly increases risks of limb amputation and premature death.
- Understanding risk factors for adverse outcomes in CN is critical for patient management.
Purpose of the Study:
- To determine amputation and mortality rates in patients with active CN.
- To identify participant and CN characteristics associated with increased risk of amputation and mortality.
Main Methods:
- A retrospective, single-center study included 186 participants with active CN and type 1 or type 2 diabetes.
- Data were collected from January 2007 to September 2022.
- Participant and CN characteristics were analyzed for associations with amputation or mortality.
Main Results:
- The 1-, 5-, and 10-year mortality rates were 2.7%, 18.9%, and 40%, respectively.
- Male sex and prior amputation were linked to higher amputation risk.
- Prior amputation and worsening chronic kidney disease stage correlated with increased mortality risk.
Conclusions:
- Patients with active CN face substantial risks of amputation and mortality.
- Multifactorial causes of death necessitate comprehensive risk factor intervention.
- Early, aggressive management strategies are recommended to mitigate adverse outcomes in CN patients.
Introduction:
Diabetes related Charcot neuro-osteoarthropathy (CN) of the foot is associated with increased risks of amputation and premature mortality. We aimed to report the amputation and mortality rates of people with active CN and identify participant and CN characteristics associated with these adverse outcomes.
Methods:
A single-center retrospective study. Participants were included if they were diagnosed with an active CN with type 1 or type 2 diabetes mellitus presenting to a specialist foot clinic between January 2007 and September 2022. Participant and CN characteristics were analyzed to determine relationships with amputation or mortality.
Results:
186 participants were included with 195 CN feet. Median follow-up was 8.2 years (IQR 5.3, 12.2). Male sex (p = 0.026) and previous amputation (p = 0.003) were associated with a significantly increased risk of amputation. The 1-year, 5-year, and 10-year mortality rates were 2.7% (5/186), 18.9% (23/122), and 40% (24/60), respectively. Previous amputation and worsening chronic kidney disease stage were associated with a significantly increased mortality risk (p = 0.005 and p = 0.027, respectively).
Conclusions:
Participants with CN had high amputation and mortality rates. The causes of death were multifactorial, suggesting clinicians should focus on early aggressive multiple risk factor intervention to reduce these adverse outcomes.
Related Concept Videos
Diabetic Neuropathy
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Complications of Diabetes Mellitus
Diabetic Foot Ulcer
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetic Nephropathy
